The Price Effect of Drug Price Ceilings: Intended and Unintended Consequences

References

• Abbott TA, Vernon JA (2007) The cost of us pharmaceutical price regulation: A financial simulation model of r&d decisions. Management Decision Econom. 28(4-5):293–306.Crossref, Google Scholar
• Andrews DWK (1993) Tests for parameter instability and structural change with unknown change point. Econometrica 61(4):821–856.Google Scholar
• Atasu A (2014) An operational look at take-back legislation. Cahoy DR, Colburn JE, eds. Law and the Transition to Business Sustainability (Springer International Publishing, Berlin), 41–55.Crossref, Google Scholar
• Batt RJ, Terwiesch C (2016) Early task initiation and other load-adaptive mechanisms in the emergency department. Management Sci. 63(11):3531–3551.Link, Google Scholar
• Bavafa H, Hitt LM, Terwiesch C (2018) The impact of e-visits on visit frequencies and patient health: Evidence from primary care. Management Sci. 64(12):5461–5480.Link, Google Scholar
• Beall RF, Nickerson JW, Attaran A (2014) Pan-canadian overpricing of medicines: A 6-country study of cost control for generic medicines. Open Medicine 8(4):e130.Google Scholar
• Berndt ER, Conti RM, Murphy SJ (2017) The landscape of us generic prescription drug markets, 2004-2016. Technical report, National Bureau of Economic Research, Cambridge, MA.Google Scholar
• Bils M, Klenow PJ (2004) Some evidence on the importance of sticky prices. J. Political Econom. 112(5):947–985.Crossref, Google Scholar
• Boston Consulting Group (2014) New rules for winning in China’s pharmaceutical market. Internet blog post, https://www.bcg.com/publications/2014/new-rules-winning-chinas-pharmaceutical-market.Google Scholar
• Brekke KR, Holmas TH, Straume OR (2011) Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment. J. Public Econom. 95(7-8):624–638.Crossref, Google Scholar
• Chen F (2007) Auctioning supply contracts. Management Sci. 53(10):1562–1576.Link, Google Scholar
• Chen JJ, Mueller V, Jia Y, Tseng SK-H (2017) Validating migration responses to flooding using satellite and vital registration data. Amer. Econom. Rev. 107(5):441–445.Crossref, Google Scholar
• Cheng T-M (2012) Early results of china’s historic health reforms: The view from minister Chen Zhu. Health Affairs 31(11):2536–2544.Crossref, Google Scholar
• Cockburn IM, Lanjouw JO, Schankerman M (2016) Patents and the global diffusion of new drugs. Amer. Econom. Rev. 106(1):136–164.Crossref, Google Scholar
• Conti RM, Berndt ER (2020) Four facts concerning competition in us generic prescription drug markets. Internat. J. Econom. Bus. 27(1):27–48.Crossref, Google Scholar
• Corbett C, Zhou D, Tang C (2004) Designing supply contract: Contract type and asymmetric information. Management Sci. 50(4):550–559.Link, Google Scholar
• Drake DF, Just RL (2016) Ignore, avoid, abandon, and embrace: What drives firm responses to environmental regulation? Atasu A, ed. Environmentally Responsible Supply Chains (Springer, New York), 199–222.Crossref, Google Scholar
• Freeman M, Savva N, Scholtes S (2021) Economies of scale and scope in hospitals: An empirical study of volume spillovers. Management Sci. 67(2):673–697.Google Scholar
• Giaccotto C, Santerre RE, Vernon JA (2005) Drug prices and research and development investment behavior in the pharmaceutical industry. J. Law Econom. 48(1):195–214.Crossref, Google Scholar
• Green LV, Savin S, Lu Y (2013) Primary care physician shortages could be eliminated through use of teams, nonphysicians, and electronic communication. Health Affairs 32(1):11–19.Crossref, Google Scholar
• Ha AY (2001) Supplier-buyer contracting: Asymmetric cost information and cutoff level policy for buyer participation. Naval Res. Logist. 48(1):41–64.Crossref, Google Scholar
• Hsiao W, Li M, Zhang S (2015) Universal health coverage: the case of China. United Nations Research Institute for Social Development. Working paper, Geneva, Switzerland.Google Scholar
• Ibanez MR, Clark JR, Huckman RS, Staats BR (2017) Discretionary task ordering: Queue management in radiological services. Management Sci. 64(9):4389–4407.Link, Google Scholar
• Ivaldi M, Jullien B, Rey P, Seabright P, Tirole J (2003) The economics of tacit collusion. Final report for DG competition, European Commission, Brussels, Belgium.Google Scholar
• Kaiser U, Mendez SJ, Rønde T, Ullrich H (2014) Regulation of pharmaceutical prices: Evidence from a reference price reform in denmark. J. Health Econom. 36:174–187.Crossref, Google Scholar
• Kc DS (2013) Does multitasking improve performance? Evidence from the emergency department. Manufacturing Service Oper. Management 16(2):168–183.Link, Google Scholar
• Kim SH, Morton FS (2015) A model of generic drug shortages: Supply disruptions, demand substitution, and price control. Working paper, Yale University, New Haven, CT.Google Scholar
• Kim S-H, Chan CW, Olivares M, Escobar G (2014) ICU admission control: An empirical study of capacity allocation and its implication for patient outcomes. Management Sci. 61(1):19–38.Link, Google Scholar
• King G, Zeng L (2001) Logistic regression in rare events data. Political Anal. 9(2):137–163.Crossref, Google Scholar
• Knittel CR, Stango V (2003) Price ceilings as focal points for tacit collusion: Evidence from credit cards. Amer. Econom. Rev. 93(5):1703–1729.Crossref, Google Scholar
• Miller AR, Tucker C (2009) Privacy protection and technology diffusion: The case of electronic medical records. Management Sci. 55(7):1077–1093.Link, Google Scholar
• Mossialos E, Ge Y, Hu J, Wang L (2016) Pharmaceutical Policy in China: Challenges and Opportunities for Reform (World Health Organization, Geneva, Switzerland).Google Scholar
• National Health and Family Planning Commission (2001) Notice of the National Health and Family Planning Commission on the Pricing of Separately-Priced Drugs, no. 13 (National Health and Family Planning Commission, Beijing, China).Google Scholar
• NDRC (2014) Notice of the National Development and Reform Commission on Promoting Drug Price Reform: Draft for Comments, no. 918 (National Development and Reform Commission, Beijing, China).Google Scholar
• Özer Ö, Raz G (2011) Supply chain sourcing under asymmetric information. Production Oper. Management 20(1):92–115.Crossref, Google Scholar
• Plambeck E, Wang Q (2009) Effects of e-waste regulation on new product introduction. Management Sci. 55(3):333–347.Link, Google Scholar
• Ramdas K, Darzi A (2017) Adopting innovations in care delivery: The case of shared medical appointments. New England J. Medicine 376:1105–1107.Crossref, Google Scholar
• Robinson JC, Whaley CM, Brown TT (2017) Association of reference pricing with drug selection and spending. New England J. Medicine 377(7):658–665.Crossref, Google Scholar
• Schelling TC (1960) The Strategy of Conflict (Harvard University Press, Cambridge, MA).Google Scholar
• Sen A, Clemente A, Jonker L (2011) Retail gasoline price ceilings and regulatory capture: Evidence from Canada. Amer. Law Econom. Rev. 13(2):532–564.Crossref, Google Scholar
• Song H, Tucker A, Graue R, Moravick S, Yang J (2020) Capacity pooling in hospitals: The hidden consequences of off-service placement. Management Sci. 66(9):3825–3842.Google Scholar
• Storath M, Weinmann A, Demaret L (2014) Jump-sparse and sparse recovery using Potts functionals. IEEE Trans. Signal Processing 62(14):3654–3666.Crossref, Google Scholar
• Sun Q, Michael A Santoro QM, Liu C, Eggleston K (2008) Pharmaceutical policy in China. Health Affairs 27(4):1042–1050.Crossref, Google Scholar
• Timoneda JC (2021) Estimating group fixed effects in panel data with a binary dependent variable: How the lpm outperforms logistic regression in rare events data. Soc. Sci. Res. 93:102486.Crossref, Google Scholar
• U.S. Food and Drug Administration (2019) Report of the Drug Shortages Task Force: Drug shortages: root causes and potential solutions (U.S. Food and Drug Administration, Washington, DC).Google Scholar
• Wang YI, Li J, Anupindi R (2021) Manufacturing and regulatory barriers to generic drug competition: A structural model approach. Working paper, University of Michigan, Ann Arbor.Google Scholar
• World Health Organization (2015) WHO Guideline on Country Pharmaceutical Pricing Policies (World Health Organization, Geneva, Switzerland).Google Scholar
• Xu J, Forman C, Hu YJ (2019) Battle of the Internet channels: How do mobile and fixed-line quality drive Internet use? Inform. Systems Res. 30(1):65–80.Link, Google Scholar
• Yadav P, Smith L (2014) Pharmaceutical company strategies and distribution systems in emerging markets. Culyer AJ, ed. Encyclopedia of Health Economics (Elsevier, San Diego, CA), 1–8.Crossref, Google Scholar
• Yang C, Li L (2010) Drug procurement bidding. China Bus. Rev. 37(1):26.Google Scholar
• Yang C, Wu L, Cai W, Zhu W, Shen Q, Li Z, Fang Y (2016) Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: A qualitative study. PLoS One. 11(10):e0165183.Crossref, Google Scholar
• Yi H, Miller G, Zhang L, Li S, Rozelle S (2015) Intended and unintended consequences of China’s zero markup drug policy. Health Affairs 34(8):1391–1398.Crossref, Google Scholar